Companies accelerate shift to disposable upstream systems, fueling a single‑use bioprocess surge

- The industry continues shifting to single‑use systems, with companies adopting disposable upstream and downstream equipment earlier in development cycles. - BioPharm International reported single‑use equipment is used for at least 85% of pre‑commercial biopharma manufacturing, while WuXi Biologics announced structural completion at its Chengdu microbial commercial site. - That adoption trend is expanding CDMO demand and equipment orders as firms chase flexibility and lower fixed capital needs. (biopharminternational.com) (manilatimes.net)